You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RXRX Sale Disclosure
Bumpus Namandje · SEC Form 4 · Filed Jun 22, 2026
Sale
Calculated transaction value
$12.6K
Bumpus Namandje Director
RXRX
Transaction date
Jun 18, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 4 days later
RXRX daily price context
Close on/before transaction
$3.23
Jun 18, 2026
First close after public filing
$3.16
Jun 23, 2026
30-day return after filing
-5.7%
Through Jul 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 3,963 shares @ $3.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001601830-26-000082
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$12.6K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Jun 18, 2026 | $12.6K |
| Recursion Pharmaceuticals, Inc. RXRX | Award | Jun 17, 2026 | $0 |